Sustained Delivery Formulations Of Risperidone Compounds

Patent No. EP2152315 (titled "Sustained Delivery Formulations Of Risperidone Compounds") was filed by Indivior UK on Feb 13, 2008. The application was issued on Jan 6, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LECOMTE & PARTNERSOct 6, 2016IPSILON LUXEMBOURG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2152315

INDIVIOR UK
Application Number
EP08725543A
Filing Date
Feb 13, 2008
Status
Opposition Rejected
Dec 10, 2021
Publication Date
Jan 6, 2016